Lake Lanier Eye Care – Trademark Portfolio

Entity Type: 16

Lake Lanier Eye Care holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LAKE LANIER EYE CARE. The owner is based in Sugar Hill, GA.

5885 Cumming Hwy NE, Suite 401-402

Sugar Hill, GA 30518

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lake Lanier Eye Care's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Lake Lanier Eye Care have?

Lake Lanier Eye Care has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Lake Lanier Eye Care file in?

Lake Lanier Eye Care files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Lake Lanier Eye Care's most well-known trademarks?

Lake Lanier Eye Care's registered trademark portfolio includes well-known marks such as LAKE LANIER EYE CARE. These are among 2 currently registered trademarks in the portfolio.

What is Lake Lanier Eye Care's trademark registration success rate?

Lake Lanier Eye Care has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.